Home/Filings/4/0001209191-19-005370
4//SEC Filing

Lantz Keri 4

Accession 0001209191-19-005370

CIK 0001070336other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 4:49 PM ET

Size

5.5 KB

Accession

0001209191-19-005370

Insider Transaction Report

Form 4
Period: 2019-01-23
Lantz Keri
See Remarks
Transactions
  • Award

    Stock Option (Right to buy)

    2019-01-23+100,000100,000 total
    Exercise: $2.18Exp: 2029-01-23Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]This option vests as to 25% of the original number of shares on the first anniversary of the grant date and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter.

Issuer

ACHILLION PHARMACEUTICALS INC

CIK 0001070336

Entity typeother

Related Parties

1
  • filerCIK 0001762858

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:49 PM ET
Size
5.5 KB